164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (TNBC): Results from KEYNOTE-355
Titel:
164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (TNBC): Results from KEYNOTE-355
Auteur:
Cescon, D.W. Schmid, P. Rugo, H.S. Im, S-A. Md Yusof, M. Gallardo, C.E. Lipatov, O. Barrios, C.H. Perez Garcia, J.M. Iwata, H. Masuda, N. Torregroza Otero, M.A. Gokmen, E. Loi, S. Haiderali, A. Zhou, X. Guo, Z. Martin Nguyen, A. Cortés, J.